Loading market dashboard
Immunome, Inc.
IMNMHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Immunome, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $600.96M | $121.96M - $1.16B | -$120.19M | $1.168 | 5 |
| Dec 2029 | $388.70M | $78.88M - $752.17M | -$77.74M | -$0.104 | 5 |
| Dec 2028 | $225.25M | $218.96M - $231.54M | -$45.05M | -$1.117 | 10 |
| Dec 2027 | $61.58M | $15.19M - $110.51M | -$12.32M | -$2.135 | 9 |
| Dec 2026 | $2.51M | $508.9K - $4.85M | -$501.5K | -$2.142 | 9 |
| Dec 2025 | $7.72M | $7.67M - $7.78M | -$1.54M | -$2.244 | 9 |
| Dec 2024 | $9.41M | $7.56M - $11.40M | -$1.88M | -$4.382 | 5 |
| Dec 2023 | $10.78M | $2.19M - $20.87M | -$2.16M | -$6.309 | 2 |
| Dec 2020 | $2.10M | $888.0K - $3.53M | $420.0K | -$8.63 | 1 |